» Articles » PMID: 29091945

Laboratory Evaluation of Immunochromatographic Rapid Diagnostic Tests for Cholera in Haiti

Overview
Journal PLoS One
Date 2017 Nov 2
PMID 29091945
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rapid diagnostic tests (RDT) for cholera are promising tools for detecting cholera in areas with limited laboratory infrastructure. However, evidence on the characteristics of the many available RDTs is scarce, and their use has been limited by suboptimal performance. We evaluated the performance characteristics of three cholera RDTs from Span Diagnostics, Artron Laboratories, and Standard Diagnostics in a regional laboratory in Haiti.

Methodology/principal Findings: We retrospectively reviewed records from May 2014 to October 2015 of a laboratory-based surveillance program for Vibrio cholerae at Hôpital Saint-Nicolas in Saint-Marc, Haiti. We compared the results of 511 Crystal VC, 129 Artron and 451 SD Bioline RDTs to bacterial culture as the gold standard. Of 905 cultures, 477 (52.7%) were positive for V. cholerae O1, of which 27.7% were serotype Inaba. No cultures grew V. cholerae O139. Sensitivity and specificity of Crystal VC were 98.6% (95%CI: 96.5%-99.6%) and 71.1% (95%CI: 64.7%-76.9%), respectively. Artron demonstrated a sensitivity of 98.6% (95%CI: 92.7%-100%) and specificity of 69.1% (95%CI: 55.2%-80.9%). SD Bioline demonstrated a sensitivity of 81.1% (95%CI: 75.6%-85.8%) and specificity of 92.8% (95%CI: 88.4%-95.9%). Crystal VC and Artron frequently showed false positive O139 bands, whereas none were seen with SD Bioline.

Conclusions/significance: There is significant variation in the performance of different cholera diagnostic RDTs. Artron and Crystal VC RDTs have high sensitivity and low specificity, while SD Bioline RDT has low to moderate sensitivity and high specificity when performed by laboratory technicians in Haiti. Study limitations included its retrospective design. The suboptimal characteristics of these tests limit their use as clinical point-of-care tests; however, they may be useful in outbreak response, surveillance, and research in resource-limited settings.

Citing Articles

Assembly and performance of a cholera RDT prototype that detects both and associated bacteriophage as a proxy for pathogen detection.

Sayeed M, Nabil I, Bhattacharjee P, Hossain M, Akter N, Akter R J Clin Microbiol. 2025; 63(2):e0144324.

PMID: 39745446 PMC: 11837499. DOI: 10.1128/jcm.01443-24.


Cholera rages in Africa and the Middle East: A narrative review on challenges and solutions.

Ahmed A, Sijercic V, Akhtar M, Elbayomy A, Marouf M, Zeleke M Health Sci Rep. 2024; 7(5):e2013.

PMID: 38742091 PMC: 11089255. DOI: 10.1002/hsr2.2013.


Estimating the proportion of clinically suspected cholera cases that are true Vibrio cholerae infections: A systematic review and meta-analysis.

Wiens K, Xu H, Zou K, Mwaba J, Lessler J, Malembaka E PLoS Med. 2023; 20(9):e1004286.

PMID: 37708235 PMC: 10538743. DOI: 10.1371/journal.pmed.1004286.


Poor Sensitivity of Stool Culture Compared to Polymerase Chain Reaction in Surveillance for in Haiti, 2018-2019.

Guillaume Y, Debela M, Slater D, Vissieres K, Ternier R, Franke M Open Forum Infect Dis. 2023; 10(6):ofad301.

PMID: 37383250 PMC: 10296062. DOI: 10.1093/ofid/ofad301.


Development of a simple, rapid, and sensitive molecular diagnostic assay for cholera.

Chakraborty S, Velagic M, Connor S PLoS Negl Trop Dis. 2023; 17(2):e0011113.

PMID: 36745674 PMC: 9934353. DOI: 10.1371/journal.pntd.0011113.


References
1.
Koski-Karell V, Farmer P, Isaac B, Campa E, Viaud L, Namphy P . Haiti's progress in achieving its 10-year plan to eliminate cholera: hidden sickness cannot be cured. Risk Manag Healthc Policy. 2016; 9:87-100. PMC: 4888864. DOI: 10.2147/RMHP.S75919. View

2.
Debes A, Ateudjieu J, Guenou E, Ebile W, Sonkoua I, Njimbia A . Clinical and Environmental Surveillance for Vibrio cholerae in Resource Constrained Areas: Application During a 1-Year Surveillance in the Far North Region of Cameroon. Am J Trop Med Hyg. 2016; 94(3):537-543. PMC: 4775888. DOI: 10.4269/ajtmh.15-0496. View

3.
Mukherjee P, Ghosh S, Ramamurthy T, Bhattacharya M, Nandy R, Takeda Y . Evaluation of a rapid immunochromatographic dipstick kit for diagnosis of cholera emphasizes its outbreak utility. Jpn J Infect Dis. 2010; 63(4):234-8. View

4.
Boncy J, Rossignol E, Dahourou G, Hast M, Buteau J, Stanislas M . Performance and utility of a rapid diagnostic test for cholera: notes from Haiti. Diagn Microbiol Infect Dis. 2013; 76(4):521-3. DOI: 10.1016/j.diagmicrobio.2013.03.010. View

5.
Ontweka L, Deng L, Rauzier J, Debes A, Tadesse F, Parker L . Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to Culture. PLoS One. 2016; 11(12):e0168257. PMC: 5167375. DOI: 10.1371/journal.pone.0168257. View